NYSE ARCA | ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 23.56% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 21.82% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.91% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.82% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.68% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.43% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.41% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.34% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.15% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.88% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.21% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.76% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.98% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 1.39% |
| INDV | Indivior PLC Ordinary Shares | Healthcare | Drug Manufacturers - Specialty & Generic | 1.23% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 1.18% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.05% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 0.91% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 0.90% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 0.85% |